The T cell cometh: Interplay between adaptive immunity and cytokine networks in rheumatoid arthritis

Journal of Clinical Investigation

Volumn 114, Issue 4, 2004, Pages 471-474

  Firestein, Gary S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; PROTEIN KINASE ZAP 70; TUMOR NECROSIS FACTOR ALPHA; PROTEIN TYROSINE KINASE;

AUTOIMMUNITY; CELL SELECTION; CELL SURVIVAL; CYTOKINE PRODUCTION; FIBROBLAST; HUMAN; IMMUNE RESPONSE; IMMUNITY; MACROPHAGE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; THYMOCYTE; ANIMAL; BIOLOGICAL MODEL; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; CYTOKINES; FIBROBLASTS; HUMANS; INTERLEUKIN-1; MACROPHAGES; MODELS, IMMUNOLOGICAL; POINT MUTATION; PROTEIN-TYROSINE KINASES; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85047693451     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI22651     Document Type: Review

References (28)

1. Hata, H., et al. 2004. Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J. Clin. Invest. 114:582-588. doi:10.1172/JCI200421795.
2. Pribila, J.T., and Shimizu, Y. 2003. Signal transduction events regulating integrin function and T cell migration: new functions and complexity. Immunol. Res. 27:107-128.
3. Sakaguchi, N., et al. 2003. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 426:454-460.
4. Korganow, A.S., et al. 1999. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity. 4:451-61.
5. Gringhuis, S.I., et al. 2000. Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis. J. Immunol. 164:2170-2179.
6. Firestein, G.S., and Zvaifler, N.J. 1990. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum. 33:768-773.
7. Firestein, G.S., and Zvaifler, N.J. 2002. How important are T cells in chronic rheumatoid synovitis? II. T cell-independent mechanisms from beginning to end. Arthritis Rheum. 46:298-308.
8. Nishimoto, N., et al. 2004. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 50:1761-1769.
9. Jiang, Y., et al. 2000. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum. 43:1001-1009.
10. Moreland, L.W., et al. 1999. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann. Intern. Med. 130:478-486.
11. Smeets, T.J., Kraan, M.C., Versendaal, J., Breedveld, F.C., and Tak, P.P. 1999. Analysis of serial synovial biopsies in patients with rheumatoid arthritis: description of a control group without clinical improvement after treatment with interleukin 10 or placebo. J. Rheumatol. 26:2089-2093.
12. Cannon, G.W., et al. 1989. Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum. 32:964-973.
13. Moreland, L.W., Heck, L.W., Jr., and Koopman, W.J. 1997. Biologic agents for treating rheumatoid arthritis. Concepts and progress. Arthritis Rheum. 40:397-409.
14. Kremer, J.M., et al. 2003. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. 349:1907-1915.
15. Buckner, J.H., and Nepom, G.T. 2002. Genetics of rheumatoid arthritis: is there a scientific explanation for the human leukocyte antigen association? Curr. Opin. Rheumatol. 14:254-259.
16. Nielen, M.M., et al. 2004. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 50:380-386.
17. Burger, D., and Dayer, J.M. 2002. The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction. Arthritis Res. 3(Suppl):S169-S176.
18. Johansson, A.C., Hansson, A.S., Nandakumar, K.S., Backlund, J., and Holmdahl, R. 2001. IL-10-deficient B10.Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies. J. Immunol. 167:3505-3512.
19. Alonzi, T., et al. 1998. Interleukin 6 is required for the development of collagen-induced arthritis. J. Exp. Med. 187:461-468.
20. Joosten, L.A., et al. 1997. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40:249-260.
21. Joosten, L.A., et al. 1999. IL-1 αβ blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-α blockade only ameliorates joint inflammation. J. Immunol. 163:5049-5055.
22. Guedez, Y.B., et al. 2001. Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the excitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum. 44:2413-2424.
23. Kagari, T., Doi, H., and Shimozato, T. 2002. The importance of IL-1 beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J. Immunol. 169:1459-1466.
24. Ji, H., et al. 2002. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J. Exp. Med. 196:77-85.
25. Kyburz, D., Carson, D.A., and Corr, M. 2000. The role of CD40 ligand and tumor necrosis factor alpha signaling in the transgenic K/BxN mouse model of rheumatoid arthritis. Arthritis Rheum. 43:2571-2577.
26. Kuiper, S., et al. 1998. Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis. Cytokine. 10:690-702.
27. Lubberts, E., Joosten, L.A., Helsen, M.M., and van den Berg, W.B. 1998. Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone. Cytokine. 10:361-369.
28. Allen J.B., et al. 1991. Suppression of bacterial cell wall-induced polyarthritis by recombinant gamma interferon. Cytokine. 3:98-106.